Stocks News
-
AbbVie announces that the FDA has approved Skyrizi for ulcerative colitis.
AbbVie said the much-hyped drug is now approved for four diseases spanning so-called “immune-mediated” inflammatory diseases.
Read More » -
Why is DraftKings stock soaring? Find out here
Aside from Major League Baseball and one or two professional sports, the U.S. sports schedule is entering a summer slump.…
Read More » -
How Micron Technology Can Benefit from AI Investments
Artificial intelligence (AI) continues to revolutionize industries around the world, including healthcare, retail, finance, automotive, manufacturing, and logistics, driving demand…
Read More » -
Aasaan Loans IPO Review 2024
Aasaan Loans IPO Review: Akme Fintrade India Ltd (Aasaan Loans) is preparing for its initial public offering (IPO). The IPO…
Read More » -
It’s too early to be optimistic about Tesla
In this editionStock Chart TV‘Sfinal bar, Dave analyzes the gains in the S&P 500 and Nasdaq and highlights the continued…
Read More » -
How to Earn Stable Monthly Income with Minimum Deposit Using Prop Gt Expert Advisor – Trading Systems – June 18, 2024
The path to a stable income for a trader is often considered one of the most difficult. According to statistics,…
Read More » -
Emerging Market Links + The Week Ahead (June 17, 2024)
Last week, there were apparently stories circulating the crypto world and the Twittersphere that a so-called Petrodollar agreement between the…
Read More » -
Collins said the Fed’s policy patience is warranted amid still high inflation.
Boston Federal Reserve President Susan Collins warned Tuesday not to get too caught up in the latest inflation data, which…
Read More » -
Silk Road Medical Acquired by Boston Scientific, Shares Soar 24% From Investing.com
Boston Scientific (NYSE:) acquires Silk Road Medical (NASDAQ:) for $1.16 billion. The deal, disclosed Tuesday, will see Boston Scientific pay…
Read More » -
Seneca Foods: Q4 2024 Results Strong Only Via LIFO (NASDAQ:SENEA)
Susan B introduction I am at Seneca Foods (NASDAQ: SENEA) (NASDAQ:Senev) And I have written two articles about the company…
Read More »
